Back
Columbia Research Enhanced Value ETF Vs. BlueLinx Holdings Industry Stock Comparison
Buy
65
REVS
Columbia Research Enhanced Value ETF
Last Price:
24.85
Seasonality Move:
1.43%
Buy
60
BXC
BlueLinx Holdings
Last Price:
100.25
Seasonality Move:
-12.13%
Buy
65
Columbia Research Enhanced Value ETF (REVS)
is a Buy
Is Columbia Research Enhanced Value ETF a Buy, Sell or Hold?
- The current Columbia Research Enhanced Value ETF [REVS] share price is $24.89. The Score for REVS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- REVS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
BlueLinx Holdings (BXC)
is a Buy
Is BlueLinx Holdings a Buy, Sell or Hold?
- The current BlueLinx Holdings [BXC] share price is $103.63. The Score for BXC is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- BXC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
REVS Stock Price Chart
What is Columbia Research Enhanced Value ETF's stock price today?
-
The Columbia Research Enhanced Value ETF share price today is $24.89
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REVS is experiencing slight selling pressure.
BXC Stock Price Chart
What is BlueLinx Holdings's stock price today?
-
The BlueLinx Holdings share price today is $103.63
The current trend is relatively stagnant and BXC is experiencing selling pressure, which indicates risk of future bearish movement.
REVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.25 | Buy |
| Relative Strength Index (14 RSI): | 66.63 | Buy |
| Chaikin Money Flow: | -1747 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.66 - 24.56) | Buy |
| Bollinger Bands (100): | (23 - 24.04) | Buy |
BXC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.38 | Sell |
| Relative Strength Index (14 RSI): | 52.82 | Buy |
| Chaikin Money Flow: | -81302 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (94.09 - 115.09) | Sell |
| Bollinger Bands (100): | (94.22 - 114.1) | Sell |
REVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.52 | Buy |
| 20-day SMA: | 24.11 | Buy |
| 50-day SMA: | 23.79 | Buy |
| 200-day SMA: | 22.74 | Buy |
| 8-day EMA: | 24.52 | Buy |
| 20-day EMA: | 24.22 | Buy |
| 50-day EMA: | 23.9 | Buy |
| 200-day EMA: | 22.86 | Buy |
BXC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 98.59 | Buy |
| 20-day SMA: | 100.74 | Buy |
| 50-day SMA: | 101.29 | Buy |
| 200-day SMA: | 107.08 | Sell |
| 8-day EMA: | 99.92 | Buy |
| 20-day EMA: | 100.77 | Buy |
| 50-day EMA: | 102.32 | Buy |
| 200-day EMA: | 102.53 | Buy |
Columbia Research Enhanced Value ETF Earnings Growth & REVS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
BlueLinx Holdings Earnings Growth & BXC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.66 per share, an increase next quarter of $1.17 per share, a decrease this year of $4.61 per share, and an increase next year of $1.43 per share.
Columbia Research Enhanced Value ETF Technical Analysis
| Aug 13 | Aug 14 | Aug 15 | Aug 16 | Aug 19 | Aug 20 | Aug 21 | Aug 22 | Aug 23 | Aug 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BlueLinx Holdings Technical Analysis
| Aug 13 | Aug 14 | Aug 15 | Aug 16 | Aug 19 | Aug 20 | Aug 21 | Aug 22 | Aug 23 | Aug 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||